Review Registration - Consultant

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 51694216
Submitted by lobbyist on: November 4, 2019 11:09:26 AM
Accepted by Registrar on: November 4, 2019 11:22:59 AM

Lobbyist Information

Retfalvi, Andrew  
595 Bay St., Suite 401  
Toronto, ON, M5G 2C2
416-886-1255
Canada  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbyist Firm Information

Global Public Affairs  
595 Bay St., Suite 401  
Toronto, ON, M5G 2C2
416-597-3470
Canada  

Client Information

Knight Therapeutics Inc.  
Knight is a specialty pharmaceutical company focused on innovative prescription pharmaceuticals, consumer health products and medical devices in Canada.
3400 de Maisonneuve W. Suite 1055  
Montreal, QC, H3Z 3B8
514-484-4483
Canada  

Relevant Affiliates

The client has no relevant affiliates.

Government or Government Agency Funding


The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Undertaking Information

November 4, 2019  
December 31, 2019  

There are no other individuals engaged to lobby on this undertaking.



Lobbying Activities

Mental Health and Addictions

Arranging meeting between an individual and a public office holder

Arranging and attending a meeting regarding treatments for opioid use disorder under the Ministry of Health's BC Pharmacare program.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency Health November 4, 2019